the vaccine – Page 48 – Communicable Diseases Research

The Effectiveness of COVID-19 Vaccines in Improving the Outcomes of Hospitalized COVID-19 Patients

Internal Medicine

Published on 2022-01-222022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] 95%CI addition Admission Admitted Patient age analyzed Chronic kidney disease Clinical course collected Comorbidities conducted coronavirus disease country Course COVID-19 COVID-19 cases COVID-19 pandemic COVID-19 patient COVID-19 patients COVID-19 vaccine Critical cross-sectional Dammam effective vaccine Endotracheal intubation extreme group hospital Hospitalized ICU ICU admission Improving Infection intubation investigated less measure Ministry of Health Mortality mortality data Odds ratio outcome Oxygen requirements Patient patients programming reduction in mortality renal Result retrospective Safe Saudi Arabia SciPy significantly lower single dose single vaccine Spread statistical significance statistically significant the disease the vaccine vaccination Vaccine
[DOI] 10.7759/cureus.21485 PMC 바로가기 [Article Type] Internal Medicine

National COVID-19 Vaccine Program and Parent’s Perception to Vaccinate Their Children: A Cross-Sectional Study

Article

Published on 2022-01-222022-10-28
Journal: Vaccines [Category] COVID-19,

Analysis of Key Factors of a SARS-CoV-2 Vaccination Program: A Mathematical Modeling Approach

Article

Published on 2022-01-222022-10-31
Journal: Epidemiologia [Category] COVID-19,

Changes in COVID-19 Vaccine Hesitancy Among Black and White Individuals in the US

Research

Published on 2022-01-212022-10-29
Journal: JAMA Network Open [Category] COVID-19,

Humoral immune response after different SARS-CoV-2 vaccination regimens

상이한 SARS-COV-2 백신 접종 요법 후 체액 면역 반응

Research Article

Published on 2022-01-212022-09-01
Journal: BMC Medicine [Category] SARS, 변종, 진단, 치료기술,

[키워드] age Alpha anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibody Antibody Response Antigen AstraZeneca avidity AZD1222 B.1.1.7 B.1.1.7 variant B.1.617.2 binding BNT162b2 boost booster vaccination ChAdOx1 ChAdOx1 nCoV-19 comparable Concentration correlation COVID-19 cVNT delta variant examined first vaccination followed by Heterologous homologous humoral immune response Humoral immunity IgG IgG antibodies IgG antibody immune response immunoblot Immunoglobulin Immunoglobulin G individual investigation leads Maturity process Moderna mRNA mRNA vaccine neutralisation test Neutralising Antibodies Occurrence Pfizer/BioNTech Prevalence RBD Receptor binding domain recipient reduction in regimen Result robust S-protein SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 nucleoprotein SARS-CoV-2 spike SARS-CoV-2 vaccination sera Seroconversion significantly higher significantly lower strength subunit supplementary material sVNT tested the antibody response the RBD the SARS-CoV-2 the vaccine titre titres trimeric vaccination Vaccination schemes Vaccine vaccine dose vaccinee variant Virus neutralisation Virus variants of concern VoC was done was measured was used were measured
[DOI] 10.1186/s12916-021-02231-x PMC 바로가기 [Article Type] Research Article

COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil

Research Article

Published on 2022-01-212022-10-28
Journal: PLoS ONE [Category] COVID-19, SARS,

Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials

COVID-19를 예방하기위한 백신 : 무작위 임상 시험의 시험 순차 분석 및 네트워크 메타 분석을 통한 살아있는 체계적인 검토

Meta-Analysis

Published on 2022-01-212022-09-10
Journal: PLoS ONE [Category] meta-analysis, 임상,

[키워드] 95% CI 95% confidence interval all-cause mortality analyses Analysis CENTRAL certainty certainty of evidence clinical trials comparable conducted confidence interval COVID-19 COVID-19 vaccine COVID-19 vaccines database databases decreased mortality effective Effective vaccines Effectiveness Efficacy events Evidence evidence of Follow-up GRADE inactivated Inactivated vaccine Inactivated Vaccines inception increased the risk independent meta-analyses Meta-analysis moderate mRNA mRNA vaccine mRNA vaccines Network meta-analysis non-serious adverse non-serious adverse events participant Prevent prevented Primary outcome protein subunit vaccine Protein subunit vaccines randomized clinical trial randomized clinical trials randomizing reducing mortality risk risk ratio risks of bias safety profile screened searched Serious Adverse Events subunit vaccines suggested systematic review the vaccine the vaccines Trial trial sequential analyses trials TSA Vaccine vaccine efficacy Vaccines Viral Viral vector vaccine Viral vector vaccines
[DOI] 10.1371/journal.pone.0260733 PMC 바로가기 [Article Type] Meta-Analysis

Risk-Perception Change Associated with COVID-19 Vaccine’s Side Effects: The Role of Individual Differences

Article

Published on 2022-01-212022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

The Effects of Non-Pharmaceutical Interventions on COVID-19 Epidemic Growth Rate during Pre- and Post-Vaccination Period in Asian Countries

Article

Published on 2022-01-202022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies

Article

Published on 2022-01-202022-10-28
Journal: Vaccines [Category] COVID-19,